Merlin Capital’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-380,190
Closed -$1.22M 66
2022
Q4
$1.22M Sell
380,190
-158,688
-29% -$597K 2.99% 2
2022
Q3
$1.88M Buy
538,878
+13,610
+3% +$57K 4.35% 3
2022
Q2
$1.93M Buy
525,268
+24,513
+5% +$125K 3.86% 3
2022
Q1
$3.33M Sell
500,755
-28,626
-5% -$177K 4.39% 3
2021
Q4
$3.71M Buy
+529,381
New +$4.49M 4.29% 4

Other funds holding OGI

Merlin Capital's OGI Position: Q1 2023 in Review

Merlin Capital sold out of Organigram Holdings (OGI) in Q1 2023, closing a stake of 380,190 shares — an estimated $1.22M sold.

Merlin Capital first reported a position in OGI in Q4 2021 and held it in 5 quarters. The position peaked at $3.71M in Q4 2021. 111 funds tracked by Wall St. Rank hold OGI as of Q1 2023.

  • Merlin Capital reported no remaining Organigram Holdings position as of Q1 2023 after selling out during the quarter.
  • Merlin Capital sold 380,190 Organigram Holdings shares in Q1 2023, an estimated $1.22M.
  • Merlin Capital first reported a position in Organigram Holdings in Q4 2021 and held it in 5 quarters.
  • Merlin Capital's Organigram Holdings position peaked at $3.71M in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2023.

Based on Merlin Capital's 13F filing for Q1 2023, filed 16 May 2023.